Artemisinin alleviates atherosclerotic lesion by reducing macrophage inflammation via regulation of AMPK/NF-κB/NLRP3 inflammasomes pathway
Author:
Affiliation:
1. Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China;
2. Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, People’s Republic of China
Funder
Key Science and Technology Project of Liaoning Province
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2019.1616296
Reference52 articles.
1. Inflammation as target in cancer therapy
2. Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model
3. Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases
4. Modafinil attenuates inflammation via inhibiting Akt/NF-κB pathway in apoE-deficient mouse model of atherosclerosis
5. NLRP3 Inflammasomes Show High Expression in Aorta of Patients with Atherosclerosis
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Extracts from Artemisia annua Alleviates Myocardial Remodeling through TGF-β1/Smad2/3 Pathway and NLRP3 Inflammasome;Current Molecular Pharmacology;2024-07-11
2. The Protective Effect of Dihydroartemisinin on Type 2 Diabetic Mice via Regulating Hepatic Glucose Output;Journal of Biomedical Nanotechnology;2024-02-01
3. Aqueous M. oleifera leaf extract alleviates DSS-induced colitis in mice through suppression of inflammation;Journal of Ethnopharmacology;2024-01
4. AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration;Biogerontology;2023-11-02
5. Medicinal and mechanistic overview of artemisinin in the treatment of human diseases;Biomedicine & Pharmacotherapy;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3